CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Aug. 31, 2024	Aug. 31, 2023
Operating Activities
Net (loss) earnings	$ 21,723	$ 17,738
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	(567)
Net Earnings from Continuing Operations	21,723	18,305
Impairment & divestiture (benefits) charges	0	147
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	3,514	3,426
Stock-based compensation expense	3,345	2,717
Provision (benefit) for deferred income taxes	2,684	(24)
Amortization of debt issuance costs	147	146
Other Noncash Income (Expense)	46	1,527
Changes in components of working capital and other, excluding acquisitions and divestitures:
Accounts receivable	5,479	2,517
Inventories	(9,306)	(4,590)
Trade accounts payable	790	(4,984)
Prepaid expenses and other assets	(9,777)	(9,089)
Income tax accounts	422	1,051
Accrued compensation and benefits	(7,470)	(11,154)
Other accrued liabilities	(2,948)	(3,912)
Cash provided by (used in) operating activities, Continuing Operations	8,649	(3,917)
Cash (used in) provided by operating activities, Discontinued Operations	0	(2,758)
Cash (Used in) Provided By Operating Activities	8,649	(6,675)
Investing Activities
Capital expenditures	(5,857)	(1,567)
Payments to Acquire Businesses, Net of Cash Acquired	27,196	0
Cash used in investing activities, Continuing Operations	(33,053)	(2,594)
Cash Provided by Investing Activities	(33,053)	(2,594)
Financing Activities
Borrowings on Revolving Credit	14,421	39,000
Principal Repayment on Revolving Credit Facility	(14,421)	(8,000)
Principal repayments on term loan	(1,250)	(625)
Taxes paid related to the net share settlement of equity awards	(6,406)	(2,081)
Stock option exercises & other	1,419	2,317
Cash dividend	(2,167)	(2,178)
Net Cash Used in Financing Activities, Continuing Operations	(12,783)	2,317
Cash used in financing activities	(12,783)	2,317
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(36,361)	(6,459)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	826	493
Payments for Repurchase of Common Stock	(4,379)	(26,116)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	130,733	147,956	$ 167,094	$ 154,415
Purchase of assets	$ 0	$ (1,027)